Investor Presentaiton
$30.1M
REPORTED EBITDA +$4.6M
+18% vs PCP
$12.8M
REPORTED NPAT
+35% vs PCP
$209M
60.3%
DELIVERING ON OUR
Plan
(NUMBERS)
18.2EPS
•
HEADLINES
•
Reported EBITDA $30.1M +18% vs PCP, at top end of
guidance
Second highest earnings of all time in the history of
Comvita
EPS +34% vs PCP
•
$12.8M NPAT +35% vs PCP
•
Record revenue $209M +9% +$17M vs PCP
.
Record gross profit $126M +22% vs PCP, on track with
2025 plan
$28.1M
MARKETING
RECORD REVENUE
GROSS PROFIT
•
INVESTMENT +16%
+9.0%
+640 BPS
COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY22
•
Double digit bottom-line growth:
•
North America
•
China
•
Mānuka honey
•
Ecommerce
$28.1M investment in our brand enabling us to tell our
founding story to consumers around the world
•
Gaining market share in key markets
8View entire presentation